XML 66 R55.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Investments in and Advances to Unconsolidated Joint Ventures - Schedule of Equity Method Investments (Details) $ in Thousands | Jun. 30, 2017 USD ($) joint_venture | Dec. 31, 2016 USD ($)
--- | --- | ---
Company owned interests in entities, accounted under equity method: |  |
Investments in and advances to unconsolidated joint ventures | $ 829,231 | $ 571,491
CCRC JV | SHOP |  |
Company owned interests in entities, accounted under equity method: |  |
Investment ownership percentage | 49.00% |
Investments in and advances to unconsolidated joint ventures | $ 433,507 | 439,449
Number of unconsolidated joint ventures | joint_venture | 2 |
RIDEA II | SHOP |  |
Company owned interests in entities, accounted under equity method: |  |
Investment ownership percentage | 40.00% |
Investments in and advances to unconsolidated joint ventures | $ 258,505 | 0
HCP Life Science | Life science |  |
Company owned interests in entities, accounted under equity method: |  |
Investments in and advances to unconsolidated joint ventures | $ 64,795 | 67,879
HCP Life Science | Life science | Minimum |  |
Company owned interests in entities, accounted under equity method: |  |
Investment ownership percentage | 50.00% |
HCP Life Science | Life science | Maximum |  |
Company owned interests in entities, accounted under equity method: |  |
Investment ownership percentage | 63.00% |
Torrey Pines Science Center, LP | Life science |  |
Company owned interests in entities, accounted under equity method: |  |
Investment ownership percentage | 50.00% |
Britannia Biotech Gateway, LP | Life science |  |
Company owned interests in entities, accounted under equity method: |  |
Investment ownership percentage | 55.00% |
LASDK, LP | Life science |  |
Company owned interests in entities, accounted under equity method: |  |
Investment ownership percentage | 63.00% |
MBK JV | SHOP |  |
Company owned interests in entities, accounted under equity method: |  |
Investment ownership percentage | 50.00% |
Investments in and advances to unconsolidated joint ventures | $ 38,806 | 38,909
Medical Office JVs | Medical office |  |
Company owned interests in entities, accounted under equity method: |  |
Investments in and advances to unconsolidated joint ventures | $ 13,569 | 13,438
Number of unconsolidated joint ventures | joint_venture | 3 |
Medical Office JVs | Medical office | Minimum |  |
Company owned interests in entities, accounted under equity method: |  |
Investment ownership percentage | 20.00% |
Medical Office JVs | Medical office | Maximum |  |
Company owned interests in entities, accounted under equity method: |  |
Investment ownership percentage | 67.00% |
HCP Ventures VI, LLC | Medical office |  |
Company owned interests in entities, accounted under equity method: |  |
Investment ownership percentage | 20.00% |
H C P Ventures III, LLC | Medical office |  |
Company owned interests in entities, accounted under equity method: |  |
Investment ownership percentage | 30.00% |
Suburban Properties, LLC | Medical office |  |
Company owned interests in entities, accounted under equity method: |  |
Investment ownership percentage | 67.00% |
Development JVs | SHOP |  |
Company owned interests in entities, accounted under equity method: |  |
Investments in and advances to unconsolidated joint ventures | $ 18,616 | 10,459
Number of unconsolidated joint ventures | joint_venture | 4 |
Development JVs | SHOP | Minimum |  |
Company owned interests in entities, accounted under equity method: |  |
Investment ownership percentage | 50.00% |
Development JVs | SHOP | Maximum |  |
Company owned interests in entities, accounted under equity method: |  |
Investment ownership percentage | 90.00% |
Vintage Park Development JV | Life science |  |
Company owned interests in entities, accounted under equity method: |  |
Investment ownership percentage | 85.00% |
Waldwick | Life science |  |
Company owned interests in entities, accounted under equity method: |  |
Investment ownership percentage | 85.00% |
Otay Ranch | Life science |  |
Company owned interests in entities, accounted under equity method: |  |
Investment ownership percentage | 90.00% |
MBK Development JV | Life science |  |
Company owned interests in entities, accounted under equity method: |  |
Investment ownership percentage | 50.00% |
K&Y JVs | Other non-reportable segments |  |
Company owned interests in entities, accounted under equity method: |  |
Investment ownership percentage | 80.00% |
Investments in and advances to unconsolidated joint ventures | $ 1,420 | 1,342
Advances to unconsolidated joint ventures, net |  |
Company owned interests in entities, accounted under equity method: |  |
Investments in and advances to unconsolidated joint ventures | $ 13 | $ 15

X
- Definition Represents number of unconsolidated joint ventures between entity and an institutional capital partner. + References No definition available. + Details
Name: | hcp_NumberOfUnconsolidatedJointVenture
Namespace Prefix: | hcp_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=66011266&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total investments in (A) an entity in which the entity has significant influence, but does not have control, (B) subsidiaries that are not required to be consolidated and are accounted for using the equity and or cost method, and (C) an entity in which the reporting entity shares control of the entity with another party or group. Includes long-term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.12) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_CcrcJvInvestmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hcp_SeniorHousingOperatingPortfolioMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_Ridea2Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_HCPLifeSciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hcp_LifescienceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_TorreyPinesScienceCenterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_BritanniaBiotechGatewayLPMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_LASDKLPMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_MbkJvMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_MedicalOfficeJVsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hcp_MedicalOfficeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_HCPVenturesVILLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_HCPVenturesIIILLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_SuburbanPropertiesLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_DevelopmentJVsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_VintageIlDevelopmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_WaldwickMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_OtayRanchMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_MbkDevelopmentJvMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_KYJVsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hcp_OtherNonReportingSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hcp_AdvancesToUnconsolidatedJointVenturesNetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |